3PROGRESS Collaborative Study Group. Randomized trial of a pefindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemie attack [ J ]. Lancet, 2001,358:1033 - 1041.
4Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcome Prevention Evaluation Study Investigatars[J]. N Engl J Med,2000,342:145 -153.
5Pedelty, Laura; Gorelick, Philip B. Chronic Management of Blood Pressure After Stroke[ J]. Hypertension, 2004,44( 1 ) : 1 -5.
6World Health Organisation. The World Health Report 2002: Reducing Risks, Promoting Health Life[R]. Geneva, Switzerland: World Health Organization ,2002.
7Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation,and Treatment of High Blood Pressure. The JNC 7 Report [ J ]. JAMA ,2003,289: 2560 -2572.
8Carlene M, Lawes M, Bennett DA, et al. Blood Pressure and Stroke[J]. Stroke,2004,35: 776-785.
9Gary F, Milton A, Sue-Min L. Control of Hypertension and Risk of Stroke Rccurrence. Stroke[J]. 2002,33 ( 11 ) : 2652 - 2657.
10Donnan GA, Davis SM, Thrift A. The role of blood pressure lowering before and after stroke [J]. Current Opinion in Neurology,2003,16:81 - 86.
